“Safe Baby Products Act”
This article was originally published in The Rose Sheet
Executive Summary
Sen. Kirsten Gillibrand, D-N.Y., introduces the "Safe Baby Products Act," which directs FDA to investigate cosmetics and personal care marketed to and used by children, according to April 29 release. Bill directs FDA "to test a wide range of children's personal-care products, publicly report the findings and establish good manufacturing practices to reduce or eliminate hazardous contaminants from products." The legislation responds to the Campaign for Safe Cosmetics' "Toxic Tub" report, which analyzed and identified children's products containing suspected carcinogens 1,4-dioxane and formaldehyde. At the time of the report's release, Gillibrand said she would explore legislation putting onus on FDA to more closely scrutinize baby products (1"The Rose Sheet" March 23, 2009, p. 3). Sens. Dianne Feinstein, D-Calif., and Charles Schumer, D-N.Y., are co-sponsors. Lisa Archer of the Campaign for Safe Cosmetics states: "This bill is a good step forward. ... Next we need to overhaul cosmetics laws so the FDA can fully assess and assure the safety of all personal-care products.
You may also be interested in...
More “Toxic Tub” Fallout: Senator Gillibrand Decries “Total Lack Of Oversight”
Sen. Kirsten Gillibrand, D-N.Y., is the latest Democrat to speak out about what she perceives as "a complete and total lack of oversight" in the personal-care sector, based on findings from the Campaign for Safe Cosmetics "Toxic Tub" report
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.